Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001604867-25-000004·FENNEC PHARMACEUTICALS INC.
Schedule 13G ownership disclosure
Fennec Pharmaceuticals Inc
Common Shares, no par value · CUSIP: 31447P100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Solas Capital Management, LLC
Shares: 2,250,919.00 · Class: 8.2%
- FREDERICK TUCKER GOLDEN
Shares: 2,250,919.00 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001604867-25-000004
- Form type
- SCHEDULE 13G/A
- Filer
- FENNEC PHARMACEUTICALS INC.
- CIK
- CIK 1211583
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership